ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "disability and longitudinal studies"

  • Abstract Number: 2857 • 2014 ACR/ARHP Annual Meeting

    Restricting Back Pain Is Strongly Associated with Disability in Community-Living Older Persons over the Course of 13 Years

    Una Makris1,2, Liana Fraenkel3, Ling Han4, Linda Leo-Summers4 and Thomas M. Gill5, 1Rheumatology, UT Southwestern Medical Center, Dallas, UT, 2Rheumatology, Dallas VA Medical Ctr, Dallas, TX, 3Rheumatology, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare Systems, New Haven, CT, 4Internal Medicine, Department of Medicine, New Haven, CT, 5Internal Medicine, Section of Geriatrics, Yale University, New Haven, CT

    Background/Purpose: Although back pain is common and costly, few longitudinal studies have evaluated the association between back pain severe enough to restrict activity [hereafter referred…
  • Abstract Number: 2392 • 2014 ACR/ARHP Annual Meeting

    Anti-Carbamylated Antibodies (anti-CarPA) Are Associated with Long Term Disability and Increased Disease Activity in Patients with Early Inflammatory Arthritis: Results from the Norfolk Arthritis Register (NOAR)

    Jenny H. Humphreys1, Marije K Verheul2, Anne Barton3,4, Tarnya Marshall5, Bo Fu6, René E.M. Toes7, Deborah PM Symmons1,4, Leendert A. Trouw7 and Suzanne MM Verstappen1, 1Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Arthritis Research UK Centre for Genetics and Genomics, University of Manchester, Manchester, United Kingdom, 4NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester Academic Health Science Centre, Manchester, United Kingdom, 5Rheumatology, Norfolk and Norwich University Hospitals Trust, Norwich, United Kingdom, 6Centre for Biostatistics, Institute of Population Health, The University of Manchester, Manchester, United Kingdom, 7Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Anti-CarPA have been shown to predict development of rheumatoid arthritis (RA) in patients with arthralgia.  However, little is known about their association with disease…
  • Abstract Number: 2854 • 2013 ACR/ARHP Annual Meeting

    Restricting Back Pain and Subsequent Mobility Disability In Community-Living Older Persons

    Una E. Makris1, Liana Fraenkel2, Ling Han3, Linda Leo-Summers3 and Thomas M. Gill4, 1Rheumatology, UT Southwestern Medical Center, VA Medical Center, Dallas, TX, 2Medicine, Section of Rheumatology, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, New Haven, CT, 3Internal Medicine, Department of Medicine, New Haven, CT, 4Internal Medicine, Section of Geriatrics, Yale University, New Haven, CT

    Background/Purpose: Although back pain is common and costly, few longitudinal studies have evaluated the association between back pain, severe enough to restrict activity (hereafter referred…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology